SCHEMBL15925262

SCHEMBL15925262

CC(=O)Nc1ccc(Oc2ccnc3[nH]c(=O)cnc23)cc1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRAF P15056 17/20 0.62
KMT2A Q03164 1/20 0.52
IKBKB O14920 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2930178 0.89 BRAF (0.63) BRAF
SCHEMBL3757667 0.85 BRAF (0.59) BRAF
SCHEMBL15925259 0.82 BRAF (0.69) BRAF
SCHEMBL12455757 0.80 BRAF (0.52) BRAF
SCHEMBL9909763 0.79 BRAF (0.53) BRAF
SCHEMBL15925263 0.79 BRAF (0.60) BRAFKMT2A
SCHEMBL28707059 0.77 BRAF (0.56) BRAF
SCHEMBL2931091 0.77 BRAF (1.00) BRAF
SCHEMBL2937399 0.77 BRAF (0.48) BRAF
SCHEMBL2935268 0.76 BRAF (0.68) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229391-B1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER REC TECH LTD (GB) 2014-08-06 EP disclosed